1. Murea M, Ma L, Freedman BI. Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications. Rev Diabet Stud. 2012;9(1):6-22. [DOI:10.1900/RDS.2012.9.6] [PMID] []

2. Oguntibeju OO. Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. IJPPP. 2019;11(3):45-63.

3. Abeyrathna P, Su Y. The critical role of Akt in cardiovascular function. Curr. Vasc. Pharmacol.2015;74:38-48. [DOI:10.1016/j.vph.2015.05.008] [PMID] []

4. Zdychová J, Komers R. Emerging role of Akt kinase/protein kinase B signaling in pathophysiology of diabetes and its complications. Physiol Res. 2005;54:1. [DOI:10.33549/physiolres.930582] [PMID]

5. Bernal-Mizrachi E, Wen W, Stahlhut S, Welling CM, Permutt MA. Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J Clin Invest. 2001;108(11):1631-8. [DOI:10.1172/JCI200113785] [PMID] []

6. Jiang ZY, Zhou QL, Coleman KA, Chouinard M, Boese Q, Czech MP. Insulin signaling through akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing. PNAS. 2003;100:7569-74. [DOI:10.1073/pnas.1332633100] [PMID] []

7. Beg M, Abdullah N, Thowfeik FS, Altorki NK, McGraw TE. Distinct Akt phosphorylation states are required for insulin regulated Glut4 and Glut1-mediated glucose uptake. eLife. 2017;6:e26896. [DOI:10.7554/eLife.26896] [PMID] []

8. De Oliveira TM, de Carvalho RBF, da Costa IHF, de Oliveira GAL, de Souza AA, de Lima SG, et al. Evaluation of p-cymene, a natural antioxidant. Pharm Bio. 2015;53:423-8. [DOI:10.3109/13880209.2014.923003] [PMID]

9. Quintans-Júnior L, Moreira JC, Pasquali MA, Rabie SM, Pires AS, Schröder R, et al. Antinociceptive Activity and Redox Profile of the Monoterpenes (+)-Camphene, p-Cymene, and Geranyl Acetate in Experimental Models. ISRN Toxicol. 2013;2013:459530. [DOI:10.1155/2013/459530] [PMID] []

10. Haribabu J, Ranade DS, Bhuvanesh NSP, Kulkarni PP, Karvembu R. Ru(II)-p-cymene thiosemicarbazone complexes as inhibitors of amyloid β (Aβ) peptide aggregation and Aβ-induced cytotoxicity. Chemistry Select. 2017;2(35):11638-44. [DOI:10.1002/slct.201702390]

11. Seifi-Nahavandi B, Yaghmaei P, Ahmadian S, Ghobeh M, Ebrahim-Habibi A. Cymene consumption and physical activity effect in Alzheimer's disease model: an in vivo and in vitro study. J Diabetes Metab Disord. 2020;19(2):1381-89. [DOI:10.1007/s40200-020-00658-2] [PMID] []

12. Wang S, Wang X, Wang Y, Leng Q, Sun Y, Hoffman RM, eta al. The Anti-oxidant Monoterpene p-Cymene Reduced the Occurrence of Colorectal Cancer in a Hyperlipidemia Rat Model by Reducing Oxidative Stress and Expression of Inflammatory Cytokines. Anticancer Res. 2021;41(3):1213-18. [DOI:10.21873/anticanres.14878] [PMID]

13. Rahimpour P, Sheikholeslami-Vatani D, Moloudi M, Ghaeeni S. The effect of training type on the signaling Pathway of ceramide-dependent insulin resistance in the flexor hallucis longus muscle of streptozotocin-induced diabetic rats. Cell J. 2023;25(7):461-9.

14. de Oliveira TM, de Carvalho RBF, da Costa IHF, de Oliveira GAL, de Souza AA, de Lima SG, et al. Evaluation of p-cymene, a natural antioxidant. Pharm Biol. 2015;53(3):423-8. [DOI:10.3109/13880209.2014.923003] [PMID]

15. Lotfi P, Yaghmaei P, Ebrahim-Habibi A. Cymene and Metformin treatment effect on biochemical parameters of male NMRI mice fed with high fat diet. J Diabetes Metab Disord. 2015;14:52. [DOI:10.1186/s40200-015-0182-x] [PMID] []

16. Poorgholam P, Yaghmaei P, Noureddini M, Hajebrahimi Z. Effects of artemisinin and TSP‑1‑human endometrial‑derived stem cells on a streptozocin‑induced model of Alzheimer's disease and diabetes in Wistar rats. Acta Neurobiol Exp. 2021;81(2):141-150. [DOI:10.21307/ane-2021-013]

17. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of"antioxidant power": the FRAP assay. Anal Biochem. 1996;239(1):70-6. [DOI:10.1006/abio.1996.0292] [PMID]

18. Ahmadi A, Vahabzadeh Z, Moloudi M, Farhadi L, Shirahmadi S. Contribution of toll-like receptor 2 and nicotinamide adenine dinucleotide phosphate oxidase to the trimethylamine N-oxide-induced inflammatory reactions in U937-derived macrophages. ARYA Atheroscler. 2021;17:2096.

19. Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia. 2008;51(2):216-26. [DOI:10.1007/s00125-007-0886-7] [PMID]

20. Nukatsuka M, Yoshimura Y, Nishida M, Kawada J. Allopurinol protects pancreatic beta cells from the cytotoxic effect of streptozotocin: in vitro study. J Pharmacobiodyn. 1990;13:259-62. [DOI:10.1248/bpb1978.13.259] [PMID]

21. Nogueira-Machado JA, Chaves MM. From hyperglycemia to AGE-RAGE interaction on the cell surface: a dangerous metabolic route for diabetic patients. Expert Opin Ther Targets. 2008;12:871-82. [DOI:10.1517/14728222.12.7.871] [PMID]

22. Rong Y, McPhee C K, Deng S, Huang L, Chen L, Liu M, et al. Spinster is required for autophagic lysosome reformation and mTOR reactivation following starvation. Proc Natl Acad Sci USA 2011;108(19):7826-31. [DOI:10.1073/pnas.1013800108] [PMID] []

23. Chetram MA, Bethea DA, Jones KJ, Don-Salu-Hewage AS, Odero-Marah VA, Hinton CV. ROS-mediated activation of AKT induces apoptosis via pVHL in prostate cancer cells. Mol Cell Biochem. 2013;376(1-2):63-71. [DOI:10.1007/s11010-012-1549-7] [PMID] []

24. Wen C, Wang H, Wu X, He L, Zhou Q, Wang F, et al. ROS-mediated inactivation of the PI3K/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin. Cell Death Dis. 2019;10(11):809. [DOI:10.1038/s41419-019-2035-x] [PMID] []

25. Li X, Song D, Leng SX. Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment. Clin Interv Aging. 2015;10:549-60. [DOI:10.2147/CIA.S74042] [PMID] []

26. Balcazar N, Sathyamurthy A, Elghazi L, Gould A, Weiss A, Shiojima I, et al. mTORC1 activation regulatesbeta-cell mass and proliferation by modulation of cyclin D2 synthesis andstability. J Biol Chem. 2009;284:7832-42. [DOI:10.1074/jbc.M807458200] [PMID] []

27. Stamateris RE, Sharma RB, Kong Y, Ebrahimpour P, Panday D, Ranganath P, et al. Glucose induces mouse b-cell proliferation via IRS2, MTOR, and cyclin D2 but not the insulin receptor. Diabetes. 2016;65:981-95. [DOI:10.2337/db15-0529] [PMID] []